Literature DB >> 15102801

Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway.

Rena J Menaker1, Peter J M Ceponis, Nicola L Jones.   

Abstract

Helicobacter pylori is a gastric bacterial pathogen that evades host immune responses in vivo and is associated with the development of gastritis, peptic ulcer disease, and gastric cancers. Induction of macrophage apoptosis is a method employed by multiple pathogens to escape host immune responses. Therefore, we hypothesized that H. pylori induces apoptosis of infected macrophages. RAW 264.7 cells were infected with H. pylori strain 60190, and apoptosis was assessed. Transmission electron microscopy and fluorescence microscopy showed that infected macrophages displayed morphological features characteristic of apoptosis. Quantification by acridine orange-ethidium bromide fluorescent-dye staining showed that apoptosis was dose and time dependent, and apoptosis was further confirmed by increased binding of annexin V-fluorescein isothiocyanate (FITC) to externalized phosphatidylserine of infected but not of control macrophages. Macrophages infected with isogenic mutants of H. pylori strain 60190 deficient in either cagA or vacA induced significantly less apoptosis than the parental strain, as assessed by increased binding of annexin V-FITC. Western blot analysis of whole-cell protein lysates revealed that infection with strain 60190 induced a time-dependent increase in cleavage of procaspase 8 and disappearance of full-length Bid compared with uninfected cells. Furthermore, pharmacological inhibition of caspase 8 caused a decrease in levels of apoptosis. Finally, infection caused a time-dependent increase in mitochondrial-membrane permeability and release of cytochrome c into the cytosol. These results suggest that H. pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Elimination of this key immunomodulatory cell may represent a mechanism employed by the bacterium to evade host immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102801      PMCID: PMC387848          DOI: 10.1128/IAI.72.5.2889-2898.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  74 in total

1.  Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the apoptotic signaling cascade upstream of bid.

Authors:  G Denecker; W Declercq; C A Geuijen; A Boland; R Benabdillah; M van Gurp; M P Sory; P Vandenabeele; G R Cornelis
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

2.  Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion.

Authors:  J Wang; E G Brooks; K B Bamford; T L Denning; J Pappo; P B Ernst
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

3.  Identification of a tyrosine-phosphorylated 35 kDa carboxy-terminal fragment (p35CagA) of the Helicobacter pylori CagA protein in phagocytic cells: processing or breakage?

Authors:  S Moese; M Selbach; U Zimny-Arndt; P R Jungblut; T F Meyer; S Backert
Journal:  Proteomics       Date:  2001-04       Impact factor: 3.984

4.  Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells.

Authors:  S Backert; S Moese; M Selbach; V Brinkmann; T F Meyer
Journal:  Mol Microbiol       Date:  2001-11       Impact factor: 3.501

5.  Cytochrome c release upon Fas receptor activation depends on translocation of full-length bid and the induction of the mitochondrial permeability transition.

Authors:  Marco Tafani; Natalie O Karpinich; Kathryn A Hurster; John G Pastorino; Timothy Schneider; Matteo A Russo; John L Farber
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

6.  Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells.

Authors:  S Maeda; M Akanuma; Y Mitsuno; Y Hirata; K Ogura; H Yoshida; Y Shiratori; M Omata
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

7.  Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms.

Authors:  C A Belmokhtar; J Hillion; E Ségal-Bendirdjian
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

8.  Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling.

Authors:  Nicola L Jones; Andrew S Day; Hilary Jennings; Patrick T Shannon; Esther Galindo-Mata; Philip M Sherman
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 9.  Living dangerously: how Helicobacter pylori survives in the human stomach.

Authors:  C Montecucco; R Rappuoli
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

10.  cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells.

Authors:  S Keates; S Sougioultzis; A C Keates; D Zhao; R M Peek; L M Shaw; C P Kelly
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

View more
  28 in total

1.  Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis.

Authors:  Manuel Koch; Hans-Joachim Mollenkopf; Uwe Klemm; Thomas F Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

2.  Distinct patterns of mucosal apoptosis in H pylori-associated gastric ulcer are associated with altered FasL and perforin cytotoxic pathways.

Authors:  Heitor-S-P Souza; Marcelo-S Neves; Celeste-C-S Elia; Claudio-J-A Tortori; Ilana Dines; Cesonia-A Martinusso; Kalil Madi; Leonardo Andrade; Morgana-T-L Castelo-Branco
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 3.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

4.  Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer.

Authors:  Faisal Aziz; Wei Gao; Qiu Yan
Journal:  Pathol Oncol Res       Date:  2016-10-18       Impact factor: 3.201

Review 5.  H. pylori infection, inflammation and gastric cancer.

Authors:  Qurteeba Qadri; Roohi Rasool; G M Gulzar; Sameer Naqash; Zafar A Shah
Journal:  J Gastrointest Cancer       Date:  2014-06

6.  The 3'-to-5' exoribonuclease (encoded by HP1248) of Helicobacter pylori regulates motility and apoptosis-inducing genes.

Authors:  Ming-Yang Tsao; Tzu-Lung Lin; Pei-Fang Hsieh; Jin-Town Wang
Journal:  J Bacteriol       Date:  2009-02-13       Impact factor: 3.490

7.  Helicobacter pylori VacA toxin/subunit p34: targeting of an anion channel to the inner mitochondrial membrane.

Authors:  Grazyna Domańska; Christian Motz; Michael Meinecke; Anke Harsman; Panagiotis Papatheodorou; Boris Reljic; Elke A Dian-Lothrop; Antoine Galmiche; Oliver Kepp; Lars Becker; Kathrin Günnewig; Richard Wagner; Joachim Rassow
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

8.  Role of urease in megasome formation and Helicobacter pylori survival in macrophages.

Authors:  Justin T Schwartz; Lee-Ann H Allen
Journal:  J Leukoc Biol       Date:  2006-03-16       Impact factor: 4.962

9.  Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice.

Authors:  Maria Kaparakis; Anna K Walduck; Jason D Price; John S Pedersen; Nico van Rooijen; Martin J Pearse; Odilia L C Wijburg; Richard A Strugnell
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

10.  Lactic acid bacterial extracts as anti-Helicobacter pylori: a molecular approach.

Authors:  H El-Adawi; M El-Sheekh; M Khalil; N El-Deeb; M Hussein
Journal:  Ir J Med Sci       Date:  2013-02-13       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.